BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 991 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $224,628 | -0.3% | 5,952 | +20.3% | 0.01% | +11.1% |
Q2 2023 | $225,340 | -26.4% | 4,946 | -34.5% | 0.01% | -30.8% |
Q1 2023 | $306,106 | -26.3% | 7,547 | -7.4% | 0.01% | -31.6% |
Q4 2022 | $415,252 | -5.4% | 8,147 | 0.0% | 0.02% | -13.6% |
Q3 2022 | $439,000 | -32.7% | 8,147 | -19.7% | 0.02% | -26.7% |
Q2 2022 | $652,000 | -17.8% | 10,147 | -0.7% | 0.03% | -6.2% |
Q1 2022 | $793,000 | -10.0% | 10,218 | -0.5% | 0.03% | -3.0% |
Q4 2021 | $881,000 | +6.4% | 10,267 | -0.3% | 0.03% | 0.0% |
Q3 2021 | $828,000 | +227.3% | 10,295 | +227.6% | 0.03% | +175.0% |
Q2 2021 | $253,000 | -4.5% | 3,143 | 0.0% | 0.01% | -7.7% |
Q1 2021 | $265,000 | +10.0% | 3,143 | +4.8% | 0.01% | -7.1% |
Q4 2020 | $241,000 | 0.0% | 3,000 | 0.0% | 0.01% | -6.7% |
Q3 2020 | $241,000 | -6.6% | 3,000 | 0.0% | 0.02% | -16.7% |
Q2 2020 | $258,000 | +5.7% | 3,000 | 0.0% | 0.02% | -10.0% |
Q1 2020 | $244,000 | -2.8% | 3,000 | 0.0% | 0.02% | +25.0% |
Q4 2019 | $251,000 | -6.0% | 3,000 | -1.6% | 0.02% | -15.8% |
Q3 2019 | $267,000 | +6.8% | 3,050 | 0.0% | 0.02% | -20.8% |
Q2 2019 | $250,000 | +0.8% | 3,050 | 0.0% | 0.02% | +4.3% |
Q1 2019 | $248,000 | +23.4% | 3,050 | 0.0% | 0.02% | +9.5% |
Q4 2018 | $201,000 | -15.9% | 3,050 | -1.6% | 0.02% | -4.5% |
Q3 2018 | $239,000 | +2.6% | 3,100 | -1.7% | 0.02% | -4.3% |
Q2 2018 | $233,000 | +15.3% | 3,155 | +1.8% | 0.02% | +9.5% |
Q1 2018 | $202,000 | -49.0% | 3,100 | -45.6% | 0.02% | -65.6% |
Q4 2013 | $396,000 | +7.9% | 5,700 | +1.8% | 0.06% | +1.7% |
Q3 2013 | $367,000 | -5.4% | 5,600 | 0.0% | 0.06% | -7.7% |
Q2 2013 | $388,000 | – | 5,600 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |